ReproNovo

ReproNovo was founded in 2021 by a team with proven expertise in the reproductive medicine and women’s health space. With years of immersion in this field, we possess deep knowledge of drug development, regulatory affairs and business development in these therapeutic areas, the treatment landscape and patient needs.

Our team has successfully brought numerous therapies to market. Drawing upon our in-depth experience in designing and executing clinical programs, we are strongly committed to delivering innovative therapeutics solutions for male and female infertility and pioneering treatment options for conditions like adenomyosis.

In pursuit of this objective, we have built a company aimed at addressing critical gaps in the landscape of reproductive medicine and women’s health worldwide.